血管活性肠肽在肺部感染性疾病鉴别诊断中的价值

被引：6

作者：

杨晓敏

董德琼

机构：

[1] 遵义医学院附属医院呼吸一科

来源：

重庆医学 | 2013年 / 42卷 / 24期

关键词：

肺部感染性疾病; 肺结核患者; 鉴别诊断; 血管活性肠肽; 继发型肺结核; 社区获得性肺炎;

D O I：

暂无

中图分类号：

R563.1 [肺炎];

学科分类号：

摘要：

<正>检测继发型肺结核患者和社区获得性肺炎患者血清中的血管活性肠肽(VIP)水平变化,及与Th1型细胞因子γ-干扰素(IFN-γ)、Th2型细胞因子白细胞介素-4(IL-4)的相关性,探讨VIP在肺部感染性疾病鉴别诊断中的价值。

引用

页码：2951 / 2952

页数：2

共 5 条

[1]

A novel VIP signaling pathway in Tcells cAMP-->protein tyrosine phosphatase(SHP-2)-->JAK2/STAT4-->Th1differentiation. Liu L,Yen JH,Ganea D. Peptides . 2007

[2]

c-Maf and JunB Mediation of Th2 Differentiation Induced by the Type 2 G Protein-Coupled Receptor (VPAC2) for vasoactive Intestinal peptide. Voice J,Donnelly S,Dorsam G,et al. J Immunol . 2004

[3]

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: players in innate and adaptive immunity. Ganea D,Rodriguez R,Delgado M. Cellular and Molecular Biology Letters . 2003

[4]

Granzyme B, a new player in activation-induced cell death, is down-regulated by vasoactive intestinal peptide in Th2 but not Thl effectors. Sharma V,Delgado M,Ganea D. J Immunol . 2006

[5]

Roles of vasoactive intestinal peptide (VIP) in the expression of different immune phenotypes by wild-type mice and T cell-targeted type II VIP receptor transgenic mice. Voice JK,Grinninger C,Kong Y, et al. J Immunol . 2003

← 1 →